Depression in cancer patients.
Primary care clinicians who care for cancer patients are integral to the recognition, diagnosis, and management of depression in this population. A review of risk factors that may make patients more likely to develop depression can be a useful first step in screening for depression. Several screening instruments may guide clinicians in further work-up of patients suspected of being depressed. Depression is treatable in this patient population and prompt management may have a positive impact on overall outcomes. Pharmacologic and psychotherapeutic treatment options are numerous, and consideration of specific cancer treatments, including side-effect profiles, patient comorbidity, patient preference, and clinician resources, should direct management.
Snyderman
Danielle
D
Division of Geriatric Medicine, Department of Family and Community Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA. danielle.snyderman@jefferson.edu
Wynn
Daisy
D
D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D015897:Comorbidity; D003863:Depression / Q000453:epidemiology* / Q000628:therapy*; D003866:Depressive Disorder / Q000453:epidemiology* / Q000628:therapy*; D006801:Humans; D009369:Neoplasms / Q000453:epidemiology* / Q000523:psychology; D017060:Patient Satisfaction / Q000706:statistics & numerical data; D010817:Physician-Patient Relations; D011613:Psychotherapy / Q000379:methods; D011788:Quality of Life; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
D000697:Central Nervous System Stimulants